Brief: ABVC Biopharma Receives Australian TGA Approval To Initiate Phase II Study Of Vitargus
21/02/2023 14:02
Feb 21 (Reuters) - ABVC Biopharma Inc ABVC.O :
* ABVC BIOPHARMA RECEIVES AUSTRALIAN TGA APPROVAL TO
INITIATE
PHASE II STUDY OF VITARGUS®
Source text for Eikon: ID:nGNXcdG3dn
Further company coverage: ABVC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ABVC Biopharma
See all newsBrief: ABVC Biopharma Says Biokey Share Distribution Rescheduled For August 21
NASDAQ RESUMED AT 09:05 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 04:43 PM
Brief: ABVC Biopharma - Quarterly Period Ended September, 2025 Financial Statements Should Not Be Relied Upon